Study of XL999 in Adults With Solid Tumors
NCT00104117
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Interventions
DRUG:
XL999
Sponsor
Symphony Evolution, Inc.